Discovery and preliminary characterization of novel tyrosine kinase inhibitors with to BTK

被引：0
|
作者：
Namdev, Nivedita D. [1 ]
Cornell-Kennon, Susan [1 ]
Yu, Yi [1 ]
Hill, Jason [1 ]
Bull, Cathy [1 ]
Volak, Laurie [1 ]
Wang, Jianqiang [1 ]
Lowe, Deirdre [1 ]
Gu, Xuibin [1 ]
Koerner, Steffi [1 ]
Moussa, Magdi [1 ]
Vensel, David [1 ]
Liu, Yanbin [1 ]
Wu, Hui [1 ]
Chen, Chang-Rung [1 ]
Dransfield, Daniel T. [1 ]
Ashwell, Mark A. [1 ]
机构：
[1] ArQule Inc, Woburn, MA USA
来源：
MOLECULAR CANCER THERAPEUTICS | 2013年 / 12卷 / 11期
关键词：
D O I：
10.1158/1535-7163.TARG-13-B270
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
B270
引用
收藏
页数：1
相关论文
共 50 条
  • [41] Differential Evolutionary Wiring of the Tyrosine Kinase Btk
    Nawaz, Hossain M.
    Kylsten, Per
    Hamada, Noriko
    Yamamoto, Daisuke
    Smith, C. I. Edvard
    Lindvall, Jessica M.
    PLOS ONE, 2012, 7 (05):
  • [42] Signalling of Bruton's tyrosine kinase, Btk
    Mohamed, AJ
    Nore, BF
    Christensson, B
    Smith, CIE
    SCANDINAVIAN JOURNAL OF IMMUNOLOGY, 1999, 49 (02) : 113 - 118
  • [43] Structure-activity relationship investigation for benzonaphthyridinone derivatives as novel potent Bruton's tyrosine kinase (BTK) irreversible inhibitors
    Wang, Beilei
    Deng, Yuanxin
    Chen, Yongfei
    Yu, Kailin
    Wang, Aoli
    Liang, Qianmao
    Wang, Wei
    Chen, Cheng
    Wu, Hong
    Hu, Chen
    Miao, Weili
    Hur, Wooyoung
    Wang, Wenchao
    Hu, Zhenquan
    Weisberg, Ellen L.
    Wang, Jinhua
    Ren, Tao
    Wang, Yinsheng
    Gray, Nathanael S.
    Liu, Qingsong
    Liu, Jing
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2017, 137 : 545 - 557
  • [44] Discovery and Characterization of Allosteric WNK Kinase Inhibitors
    Yamada, Ken
    Zhang, Ji-Hu
    Xie, Xiaoling
    Reinhardt, Juergen
    Xie, Amy Qiongshu
    LaSala, Daniel
    Kohls, Darcy
    Yowe, David
    Burdick, Debra
    Yoshisue, Hajime
    Wakai, Hiromichi
    Schmidt, Isabel
    Gunawan, Jason
    Yasoshima, Kayo
    Yue, Q. Kimberley
    Kato, Mitsunori
    Mogi, Muneto
    Idamakanti, Neeraja
    Kreder, Natasha
    Drueckes, Peter
    Pandey, Pramod
    Kawanami, Toshio
    Huang, Waanjeng
    Yagi, Yukiko I.
    Deng, Zhan
    Park, Hyi-Man
    ACS CHEMICAL BIOLOGY, 2016, 11 (12) : 3338 - 3346
  • [45] Bruton's tyrosine kinase (BTK) inhibitors alter blood glucose and insulin in obese mice but reduce inflammation independent of BTK
    Chan, Darryl Y.
    Barra, Nicole G.
    Fang, Han
    e-Lacerda, Rodrigo Rodrigues
    Schertzer, Jonathan D.
    AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM, 2024, 327 (03): : E271 - E278
  • [46] Discovery of novel sphingosine kinase 1 inhibitors
    Xiang, Yibin
    Asmussen, Gary
    Booker, Michael
    Hirth, Bradford
    Kane, John L., Jr.
    Liao, Junkai
    Noson, Kevin D.
    Yee, Christopher
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2009, 19 (21) : 6119 - 6121
  • [47] Discovery of novel TAM family kinase inhibitors
    Zhang, Zaihui
    Li, Rick
    Lee, Erica
    Hu, Yuxiang
    Yan, Jun
    Sanghera, Jasbinder
    CANCER RESEARCH, 2014, 74 (19)
  • [48] Emerging small-molecule inhibitors of the Bruton's tyrosine kinase (BTK): Current development
    Liu, Jiakuo
    Chen, Chengjuan
    Wang, Dongmei
    Zhang, Jie
    Zhang, Tiantai
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2021, 217
  • [49] The potential of Bruton's tyrosine kinase (BTK) inhibitors in the pharmacotherapeutic management of immune and dermatological disease
    Tseng, Henry
    Murrell, Dedee F.
    EXPERT OPINION ON PHARMACOTHERAPY, 2024, 25 (12) : 1657 - 1665
  • [50] Advances in Bruton tyrosine kinase (Btk) inhibition are steered by Bruton tyrosine kinase phylogeny
    Minotti, Giorgio
    Camilli, Massimiliano
    Salvatorelli, Emanuela
    Menna, Pierantonio
    BRITISH JOURNAL OF PHARMACOLOGY, 2025, 182 (07) : 1446 - 1451
12345